Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
Yasunaga
C
C
Department of Surgery, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, California 90211.
Cramer
D V
DV
Chapman
F A
FA
Wang
H K
HK
Barnett
M
M
Wu
G D
GD
Makowka
L
L
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology*; D006967:Hypersensitivity / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D016038:Skin Transplantation / Q000276:immunology; D011798:Quinaldines
D001713:Biphenyl Compounds; D007166:Immunosuppressive Agents; C046943:brequinar; D011798:Quinaldines